The SGX942 Phase II Trial
Richard Straube, MD, Senior VP, Chief Medical Officer at Soligenix, Inc. explains the Phase II SGX942 trial.
About is a member of the (www.Oncology.TV) family of medical education websites. offers physicians, nurses, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about supportive care in cancer.